États-Unis · Plateformes & données · MarketBeat

Black Diamond Therapeutics (NASDAQ:BDTX) Issues Quarterly Earnings Results, Misses Expectations By $0.08 EPS

Publié par MarketBeat · États-Unis il y a 47 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Black Diamond Therapeutics (NASDAQ:BDTX - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.09) by ($0.08).

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Black Diamond Therapeutics (NASDAQ:BDTX) Issues Quarterly Earnings Results, Misses Expectations By $0.08 EPS

Résumé détaillé

À lire aussi

Harrow stock jumps as eye-care products deliver record Q3 sales

Fed Governor Christopher Waller Just Said 21 Words That Could Challenge the Stock Market Through Year End

‘We had the worst fight’: I want my husband to retire at 65, but I don’t want to lose his $280,000 salary. Is that unreasonable?

Earnings call transcript: Safe Bulkers tops Q3 2026 estimates as shares rise

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Polymarket says annualized revenue has topped $1.8 billion

Black Diamond Therapeutics (NASDAQ:BDTX) Issues Quarterly Earnings Results, Misses Expectations By $0.08 EPS

Résumé détaillé

Partager

À lire aussi

Harrow stock jumps as eye-care products deliver record Q3 sales

Fed Governor Christopher Waller Just Said 21 Words That Could Challenge the Stock Market Through Year End

‘We had the worst fight’: I want my husband to retire at 65, but I don’t want to lose his $280,000 salary. Is that unreasonable?

Earnings call transcript: Safe Bulkers tops Q3 2026 estimates as shares rise

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Polymarket says annualized revenue has topped $1.8 billion